Literature DB >> 29526277

Idiopathic Restrictive Cardiomyopathy in Children and Young Adults.

Heather N Anderson1, Frank Cetta2, David J Driscoll2, Timothy M Olson2, Michael J Ackerman3, Jonathan N Johnson4.   

Abstract

Idiopathic restrictive cardiomyopathy (IRC) is a rare condition characterized by reduced ventricular compliance. Children with IRC have poor outcomes with most patients proceeding to cardiac transplantation. We sought to analyze our institutional experience and assess contemporary outcomes for children with IRC. We reviewed the medical record for patients (<21 years old) evaluated for a primary diagnosis of IRC between 1975 and 2013 at our institution. Demographic, clinical, echocardiographic, and catheterization data were abstracted. The patients were divided into 2 groups comprising a historical cohort (HC) (diagnosis: 1975 to 1993, n = 8) and a contemporary cohort (CC) (diagnosis: 1994 to 2013, n = 12). Twenty children were identified with IRC (mean age at presentation 9.7 ± 6.5 years, 55% female). Mean length of follow-up was 6.5 ± 8.4 years (range 0.1 to 35.6 years). In the CC, 7 of 12 patients (58%) progressed to cardiac transplantation (mean age of 9 ± 4 years at transplant, mean interval from diagnosis of IRC: 1.5 ± 0.9 years). Overall survival was improved significantly in the CC compared with the HC (80% vs. 38%, p = 0.02), but transplantation free survival was no different between the CC and HC over 5 years (38% vs 38%, p = 0.65). In the CC, elevation of mitral valve Doppler E/e' ratio on echocardiography was associated with increased mortality (p = 0.01). In conclusion, IRC continues has a poor prognosis. Early referral for transplantation was associated with improved overall survival in the modern era. Patients with markedly elevated E/e' ratio may have increased risk of death.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29526277     DOI: 10.1016/j.amjcard.2018.01.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Reversal of pulmonary hypertension in paediatric patients with restrictive cardiomyopathy.

Authors:  Johanna Schlein; Julia Riebandt; Günther Laufer; Daniel Zimpfer
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29

Review 2.  Overview of Restrictive Cardiomyopathies.

Authors:  Smitha Narayana Gowda; Hyeon-Ju Ali; Imad Hussain
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-03-14

Review 3.  Multimodality Cardiac Imaging in Cardiomyopathies: From Diagnosis to Prognosis.

Authors:  Guillem Casas; José F Rodríguez-Palomares
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

4.  Atomic force microscopy identifies the alteration of rheological properties of the cardiac fibroblasts in idiopathic restrictive cardiomyopathy.

Authors:  Mizuki Matsumoto; Hirofumi Tsuru; Hidehiro Suginobe; Jun Narita; Ryo Ishii; Masaki Hirose; Kazuhisa Hashimoto; Renjie Wang; Chika Yoshihara; Atsuko Ueyama; Ryosuke Tanaka; Keiichi Ozono; Takaharu Okajima; Hidekazu Ishida
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

5.  Variant R94C in TNNT2-Encoded Troponin T Predisposes to Pediatric Restrictive Cardiomyopathy and Sudden Death Through Impaired Thin Filament Relaxation Resulting in Myocardial Diastolic Dysfunction.

Authors:  Jordan E Ezekian; Sarah R Clippinger; Jaquelin M Garcia; Qixin Yang; Susan Denfield; Aamir Jeewa; William J Dreyer; Wenxin Zou; Yuxin Fan; Hugh D Allen; Jeffrey J Kim; Michael J Greenberg; Andrew P Landstrom
Journal:  J Am Heart Assoc       Date:  2020-02-26       Impact factor: 5.501

6.  A Novel Case of Idiopathic Restrictive Cardiomyopathy.

Authors:  Talha Ahmed; Ayesha Safdar; Gautam Ramani
Journal:  Cureus       Date:  2020-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.